https://hub-xchange.com/antibody-therapeutics-xchange-europe-20272026-09-09T13:52:59Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/registration2026-09-09T13:18:25Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/opening-address-keynote-presentation2026-09-09T13:21:28Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/designing-complexity-with-purpose-sharing-lessons-from-the-front-lines-of-bi-and-multi-specific-antibody-development2026-09-09T13:27:50Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/1-2-1-meetings-/-networking-break2026-09-09T13:45:01Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/1-2-1-meetings-/-networking-break-12026-09-09T13:44:55Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/morning-refreshments2026-09-09T13:33:04Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/networking-lunch2026-09-09T13:44:23Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/1-2-1-meetings-/-networking-break-22026-09-09T13:34:53Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/1-2-1-meetings-/-networking-break-32026-09-09T13:44:09Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/afternoon-refreshments2026-09-09T13:45:20Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/leveraging-ai-and-early-structural-insights-to-power-rational-antibody-lead-design-and-optimization2026-09-09T13:28:43Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/drinks-canape-reception2026-09-09T13:22:34Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/poster-presentation-rapid-lead-generation-with-the-pioneer-antibody-discovery-platform2026-09-09T13:43:52Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/spotlight-presentation-accelerating-antibody-and-biologic-workflows-with-chemically-aware-macromolecule-registration2026-09-09T13:44:18Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/poster-presentation-seeing-the-drug-and-seeing-what-it-is-doing-integrated-spatial-pk/pd-analysis-for-hybrid-and-next-generation-therapeutics2026-09-09T13:47:57Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/poster-presentation-speed-counts-while-quality-matters-a-fast-track-approach-to-bispecific-antibody-production2026-09-09T13:48:02Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/balancing-potency-and-safety-in-t-cell-engaging-bispecific-antibodies-for-solid-tumors2026-09-09T13:31:24Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/designing-t-cell-engagers-for-targeting-pmhc2026-09-09T13:29:16Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/fast-fit-and-manufacturable-antibody-lead-decisions2026-09-09T13:43:00Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/addressing-engineering-challenges-with-bispecific-and-immunocytokine-drugs2026-09-09T13:44:43Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/overcoming-developability-challenges-when-designing-next-gen-bi/multi-specifics2026-09-09T13:44:33Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/careful-selection-of-building-block-properties-and-compatibility-essential-to-boost-the-overall-success-of-multispecifics2026-09-09T13:30:57Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/balancing-linker-stability-to-ensure-controlled-payload-release-without-compromising-adc-efficacy2026-09-09T13:44:40Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/-poster-presentation-designing-complexity-with-purpose-sharing-lessons-from-the-front-lines-of-bi-and-multi-specific-antibody-development2026-09-09T13:41:22Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/antibody-affinity-maturation-strategies-balancing-potency-selectivity-and-developability2026-09-09T13:30:23Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/selecting-new-classes-and-moas-for-adc-payload-discovery2026-09-09T13:45:56Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/adcs-and-payload-innovation-building-off-of-a-topo1i-world2026-09-09T13:48:06Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/developing-potent-and-safe-cytotoxins-to-reduce-severe-side-effects2026-09-09T13:44:28Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/poster-presentation-development-of-dual-payload-antibody-drug-conjugates2026-09-09T13:32:05Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/linker-selection-design-choice-or-default-choice2026-09-09T13:29:47Zhttps://hub-xchange.com/antibody-therapeutics-xchange-europe-2027/adc-payload-design-enhancing-cytotoxic-potency-while-reducing-off-target-toxicity2026-09-09T13:28:17Z